Psychedelic Depression Study - Treatment-Resistant Depression - Miami Lakes FL (Clinical Trial # 51992)

You are viewing an inactive listing

This listing is not currently available. You can either be notified when it becomes available or browse nearby active listings below.

Click here to view additional nearby listings or search by keyword.

Clinical Trial 51992

Miami Lakes, FL 33016

Summary:

Psychedelic Depression Study - Treatment-Resistant Depression

Are you or a loved one living with Depression and currently taking antidepressant medication that doesn’t seem to help?

Segal Trials is conducting an outpatient clinical research study investigating a phase III, multi center, randomized, double-blind, controlled study to investigate the efficacy, safety, and tolerability of two administrations of COMP360 in participants with treatment-resistant depression.

Qualified Participants Must:

• Men and women 18 years or older
• Diagnosed with Major Depression & past medications have failed
• Currently taking an antidepressant
• Have not been diagnosed with the following: Bipolar, Schizophrenia, PTSD, OCD, Anorexia Nervosa
• Additional criteria may apply

Qualified Participants May Receive:

•Study-related exams & lab work at no cost.

•Compensation up to $1,100 for time & travel, if qualified.

•No insurance is necessary!

Research Site Profile

Nearby listings:

Click here to view additional nearby listings or search by keyword.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.

Services for Research Sites

National Recruitment Services

News And Information